SynOx Therapeutics Employee Directory
Biotechnology ResearchDublin, Ireland11-50 Employees
SynOx Therapeutics Ltd is a Dublin, Ireland-based biotechnology research company founded in November 2020 with a team of 11-50 employees. The company is focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other CSF-1 related and macrophage-driven disorders. It is backed by a syndicate of investors with long-standing backgrounds in building biopharma companies. In 2025, SynOx Therapeutics received Fast Track Designation from the U.S. FDA for emactuzumab in TGCT, reflecting progress in its development program. The company maintains a website at synoxtherapeutics.com and has announced leadership and board appointments to support its late clinical-stage program.